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Association of DAP12 with Activating
CD94/NKG2C NK Cell Receptors
domain (designated KIR2DL and KIR3DL) recruit SHP-1
and prevent NK cell effector function (Burshtyn et al.,
1996; Campbell et al., 1996; Fry et al., 1996; Olcese et
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al., 1996). In contrast, KIR isoforms lacking ITIM andCellular Biology
having a basic K amino acid in the transmembraneImmunobiology Department
(KIR2DS and KIR3DS) have been implicated in NK cellPalo Alto, California 94304
activation (Biassoni et al., 1996; Olcese et al., 1997).
KIR2DS are noncovalently associated with an immuno-
receptor tyrosine-based activating motif (ITAM)±bearingSummary
adaptor molecule, DAP12, that is expressed on the sur-
face of NK cells as a disulfide-bonded homodimerWhile the inhibitory NK cell receptors for MHC class
(Campbell et al., 1998; Lanier et al., 1998; Olcese et al.,I express immunoreceptor tyrosine-based inhibitory
1997). Upon cross-linking of KIR2DS, tyrosine residuesmotifs that recruit intracellular tyrosine phosphatases
in the ITAM of DAP12 become phosphorylated and re-and prevent NK cell effector function, the activating
cruit ZAP-70 or Syk, resulting in cellular activation (La-NK cell receptors lack intrinsic sequences required
nier et al., 1998). Human DAP12 is present on humanfor cellular stimulation. CD94/NKG2C, an activating
chromosome 19q13.1 (Lanier et al., 1998) near the KIRNK cell receptor of the C-type lectin superfamily that
gene family (Baker et al., 1995), demonstrating a geneticbinds to HLA-E, noncovalently associates with DAP12,
linkage between KIR and DAP12.a membrane receptor containing an immunoreceptor
Another type of NK cell receptor, CD94/NKG2, is atyrosine-based activating motif. Efficient expression
heterodimer composed of an invariant CD94 glycopro-of CD94/NKG2C on the cell surface requires the pres-
tein that is disulfide-bonded to either an NKG2A or anence of DAP12, and charged residues in the trans-
NKG2C glycoprotein (Lazetic et al., 1996; Brooks et al.,membrane domains of DAP12 and NKG2C are neces-
1997; Carretero et al., 1997). CD94 (Chang et al., 1995)sary for this interaction. These results provide a
and four NKG2 genes (NKG2A, NKG2C, NKG2E, andmolecular basis for the assembly of NK cell receptors
NKG2D/F) (Houchins et al., 1991; Plougastel and Trows-for MHC class I involved in cellular activation and inhi-
dale, 1997) are all members of the C-type lectin super-bition.
family and are closely linked on human chromosome
12p12±p13 in the ªNK complexº (Renedo et al., 1997).
Introduction Rodent homologs of the human CD94 and NKG2 genes
are located in the ªNK complexº on mouse and rat chro-
NK cells are lymphocytes that participate in innate im- mosomes syntenic with human chromosome 12 (Dissen
mune responses against certain bacteria, parasites, and et al., 1997; Vance et al., 1997; Berg et al., 1998).
viruses (reviewed in Trinchieri, 1989; Scott and Trin- Antibodies against CD94 can either activate or inhibit
chieri, 1995). How NK cells recognize pathogens is un- NK cell±mediated cytotoxicity against Fc receptor±
clear; however, one aspect of this process may involve bearing targets, and different NK cell clones isolated
the detection and elimination of host cells that have from a single individual demonstrate heterogeneous be-
lost or down-regulated expression of MHC class I as a havior in these functional assays (Brumbaugh et al.,
consequence of infection. NK cells express receptors 1996; PeÂ rez-Villar et al., 1995, 1996). This phenomenon
for MHC class I that can either activate or inhibit cell- was explained by the finding that CD94 forms disulfide-
mediated cytotoxicity and cytokine production (reviewed linked heterodimers with either NKG2A or NKG2C (La-
in Lanier, 1998a, 1998b). Several types of NK cell recep- zetic et al., 1996; Brooks et al., 1997; Carretero et al.,
tors for MHC class I have been identified (Lanier, 1998a). 1997; Cantoni et al., 1998). NKG2A contains an ITIM
In humans, the killer cell inhibitory receptors (KIR) com- sequence in the cytoplasmic domain that upon receptor
prise a small family of molecules encoded by genes of ligation becomes tyrosine-phosphorylated and recruits
the Ig superfamily (Colonna and Samaridis, 1995; D'An- SHP-1 or SHP-2, which in turn inhibit NK effector func-
drea et al., 1995; Wagtmann et al., 1995a). Within the tion (Houchins et al., 1997; Le Drean et al., 1998). In
KIR family, certain isoforms possess two Ig domains contrast, NKG2C lacks an ITIM and receptor ligation
(KIR2D) or three Ig domains (KIR3D) in the extracellular results in NK cell activation (Houchins et al., 1997; Can-
region that are involved in recognition of polymorphic toni et al., 1998). CD94 is necessary to transport both
HLA-C or HLA-B ligands, respectively (Litwin et al., 1994; NKG2A and NKG2C to the cell surface (Lazetic et al.,
Wagtmann et al., 1995b; Dohring and Colonna, 1996; 1996). Within the NK cell population in an individual,
Fan et al., 1996; Rajagopalan and Long, 1997; Rojo et CD94/NKG2A and CD94/NKG2C receptors are expressed
al., 1997). Heterogeneity also exists in the transmem- on overlapping subpopulations, and some NK cells may
brane and cytoplasmic domains of different KIR mole- express CD94 proteins that are not associated with ei-
cules. Upon ligand binding, KIR having immunoreceptor ther NKG2A or NKG2C (Cantoni et al., 1998). Thus, CD94
tyrosine-based inhibitory motifs (ITIM) in their cytoplasmic and the NKG2 proteins can form a diverse receptor rep-
ertoire in an individual. CD94/NKG2A and CD94/NKG2C
receptors recognize HLA-E (Borrego et al., 1998; Braud*To whom correspondence should be addressed (e-mail: lanier@
dnax.org). et al., 1998; Lee et al., 1998b), a nonclassical MHC class
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Figure 1. Expression of CD94, NKG2, and
DAP12 on Ba/F3 Transfectants
Ba/F3 stably expressing the indicated recep-
tors were stained with: (A) control mouseIgG1
(cIg), anti-CD94 mAb, or anti-Flag mAb (to
detect Flag-DAP12 or Flag-NKG2C), or (B)
rabbit anti-CD94/NKG2 antiserum or the pre-
bleed rabbit serum (pre). Cells were analyzed
by flow cytometry and data are presented as
histograms (x axis, fluorescence, 4 decade
log scale; y axis, number of cells). Because
a mAb specific for NKG2C was not available
for certain experiments, a Flag epitope was
placed on the COOH terminus of the NKG2C
protein (as indicated) to permit detection on
the cell surface by immunofluorescence and
in the cytoplasm by Western blot analysis.
I molecule that has the unique property of binding 9 cells coinfected with both CD94 and Flag-DAP12 (Figure
1A), although Flag-DAP12 was detected in the cyto-amino acid peptides derived from the leader segments
of other classical HLA class Iproteins (Braud et al., 1997; plasm of these transfectants by Western blot and cyto-
plasmic immunofluorescence (not shown). Furthermore,Lee et al., 1998a). While the ITIM in NKG2A explains the
inhibitory function of the CD94/NKG2A receptor, neither when CD941 Ba/F3 cells were infected with a retrovirus
encoding NKG2C (Figure 1B), we were unable to detectCD94 nor NKG2C possess sequences in their cyto-
plasmic domains that provide for intrinsic signaling ca- CD94/NKG2C heterodimers on the cell surface, using
an antiserum that detects the CD94/NKG2C complexpacity. However, the existence of a basic amino acid
in the transmembrane of NKG2C suggested possible (Lazetic et al., 1996; Braud et al., 1998) (although it is
possible to obtain low levels of surface expression ofinteractions with the DAP12 receptor.
CD94/NKG2C heterodimers using episomal vectors
containing strong promoters in highly efficient transfec-Results and Discussion
tion systems such as 293T cells [Lazetic et al., 1996;
Braud et al., 1998]). When Ba/F3 cells were infected withAssociation of DAP12 with CD94/NKG2C Receptors
To determine whether DAP12 might be associated with retroviruses encoding human CD94, NKG2C, and Flag-
DAP12, we detected expression of Flag-DAP12 (Figurethe activating CD94/NKG2C receptor complex, we coin-
fected a mouse pre-B cell line, Ba/F3, with ecotropic 1A) and a CD94/NKG2C receptor (Figure 1B) on the
cell surface of the CD94/NKG2C/DAP12 transfectants.retroviruses encodinghuman CD94, NKG2C, and DAP12
(containing a Flag epitope on the N terminus to permit Collectively, these experiments support the existence
of a multisubunit receptor complex composed of CD94,detection on the cell surface). Consistent with prior re-
sults (Lanier et al., 1998), transfection of Flag-DAP12 NKG2C, and DAP12.
Ba/F3 transfectants expressing CD94, NKG2C, andalone into Ba/F3 cells does not permit cell surface ex-
pression of this receptor (Figure 1A), although Flag- Flag-DAP12 were labeled with 125I, solubilized in digito-
nin detergent to preserve noncovalentmembrane recep-DAP12 proteins were detected in the cytoplasm of these
transfectants as determined by cytoplasmic staining tor complexes (Lanier et al., 1989), and immunoprecipi-
tated with antibodies against human CD94 or Flag. Asand Western blot analysis (not shown). Similarly, we
could not detect cell surface expression of NKG2C alone shown in Figure 2, immunoprecipitation with anti-CD94
from the CD94/NKG2C/Flag-DAP12 Ba/F3 transfectantsin Ba/F3 cells (not shown) or in Flag-DAP121 Ba/F3
transfectants coinfectedwith NKG2C (Figure1A). In con- revealed 125I-labeled proteins consistent with the pre-
dicted mobility of NKG2C and Flag-DAP12. We pre-trast, CD94 alone was expressed on the cell surface of
Ba/F3 cells (Figure 1A). However, CD94 is not competent viously reported that human CD94 does not label effi-
ciently with 125I (Lazetic et al., 1996; Phillips et al., 1996),to transport Flag-DAP12 to the cell surface in Ba/F3
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Figure 3. Transmembranes of CD94, NKG2, DAP12, and KIR Pro-
teins
The consensus transmembrane segments of DAP12, CD94, NKG2A,
NKG2C, KIR2DL2, andKIR2DS2 werepredicted based onanalysis of
the protein structures using the SOSUI program, the DAS membrane
predictor server, and the TMPred program. CD94, NKG2A, and
NKG2C are type II proteins, whereasDAP12, KIR2DL2, andKIR2DS2
Figure 2. Coimmunoprecipitation of DAP12 and CD94/NKG2C are type I proteins. Locations of the cytoplasmic or extracellular
Ba/F3 cells stably expressing CD94/NKG2C/Flag-DAP12 receptors domains on the COOH side of the transmembrane segments are
were 125I labeled and lysed in digitonin detergent, and antigens were indicated. Charged amino acids in the transmembrane are bold.
immunoprecipitated with cIg, anti-Flag mAb, or anti-CD94. Samples
were analyzedby SDS±PAGE in reducing ornonreducing conditions.
1991; Cosson et al., 1991]), we examined the require-The CD94/NKG2C heterodimer migrates at z70 kDa under nonre-
ment of the D residue in DAP12 for association withducing conditions, andthe 125I-labeled NKG2C glycoprotein migrates
CD94/NKG2C. The D residue in Flag-DAP12 was con-at z40 kDa in reducing conditions. As previously reported (Lazetic
et al., 1996; Phillips et al., 1996), CD94 does not 125I-label. DAP12 verted to A by site-directed mutagenesis, and this mu-
migrates as a disulfide-bonded homodimer in nonreducing condi- tant receptor was transfected into Ba/F3 cells. Unlike
tions. wild-type Flag-DAP12 (Figure 1A), the D-A transmem-
brane Flag-DAP12 mutant receptor was expressed on
the cell surface in the absence of other subunits (Figure
so the z40 kDa radiolabeled subunit immunoprecipi- 4B), indicating that the D residue in the transmembrane
tated with anti-CD94 mAb represents an NKG2C glyco- serves as a retention signal for DAP12, similar to the
protein that is disulfide-bonded to CD94 (Lazetic et al., function of the charged residues in the transmembrane
1996). When analyzed using nonreducing conditions, of the CD3 proteins (Bonifacino et al., 1990, 1991; Cosson
Flag-DAP12 migrated predominately as a disulfide- et al., 1991). As noted previously, Ba/F3cells transfected
bonded homodimer and the mobility of NKG2C was with CD94 and NKG2C do not efficiently express a CD94/
consistent with the existence of a CD94/NKG2C hetero- NKG2C heterodimer on the cell surface in the absence
dimer. Therefore, it appears that the minimal CD94/ of DAP12 (Figure 1B). Infection of these CD94/NKG2C1
NKG2C-DAP12 receptor complex may be a tetramer Ba/F3 transfectants with the D-A transmembrane Flag-
comprised of a disulfide-linked DAP12 homodimer non- DAP12 mutant receptor did not permit efficient expres-
covalently associated with a disulfide-linked CD94/ sion of CD94/NKG2C on the cell surface (Figure 4B), as
NKG2C heterodimer. Further studies are required to es- indicated by the marginal reactivity of these cells with
tablish the stoichiometry of the native complex on the an anti-CD94/NKG2 specific antisera (although NKG2C
cell surface. proteins were detected in the cytoplasm of the transfec-
tant by Western blot analysis; not shown).
The Role of Charged Amino Acids in the Comparison of the transmembrane domains of NKG2A
Transmembrane of KIR, NKG2, and and NKG2C indicates the presence of a K residue in
DAP12 Receptors in the Assembly NKG2C, suggesting that this residue may beresponsible
of the Multisubunit Complexes for interaction with the D residue in DAP12 (Figure 3).
The NKG2A and NKG2C proteins demonstrate 75% Therefore, the K in NKG2C was converted to L by site-
amino acid identify (Houchins et al., 1991), and both directed mutagenesisand the K-L transmembraneNKG2C
CD94/NKG2A and CD94/NKG2C receptors bind to a mutant was transfected into Ba/F3 cells expressing
common ligand, HLA-E (Braud et al., 1998). A conspicu- DAP12 and CD94. As shown in Figure 4C, Ba/F3 cells
ous difference between NKG2A and NKG2C is the pres- cotransfected with CD94, and the K-L transmembrane
ence of a basic residue in the transmembrane of NKG2C NKG2C mutant receptor did not permit surface ex-
that is absent in NKG2A and CD94 (Figure 3). In contrast pression of Flag-DAP12, although DAP12 was detected
to NKG2C, infection of CD941 Ba/F3 cells with a retrovi- in the cytoplasm by Western blot analysis (not shown).
rus encoding human NKG2A permits expression of a Very low levels of a CD94/K-L transmembrane NKG2C
CD94/NKG2A complex on the cell surface in the ab- mutant receptor were detected on the surface of these
sence of DAP12 (Figure 4A). The presence of a CD94/ transfectants using an anti-CD94/NKG2C antiserum (Fig-
NKG2A complex on Ba/F3 cells does not permit expres- ure 4C). Although the K residue in the transmembrane
sion of Flag-DAP12 on the cell surface (Figure 4A), al- of NKG2C might serve as a retention signal, it should
though Flag-DAP12 proteins were detected in the cyto- be noted that NKG2C also expresses the motif DxxxLL
plasm of these transfectants by immunofluorescence that is also present in CD3g and has been implicated
and Western blot analysis (not shown). in the degradation, transport, and localization of CD3
Because other multisubunit membrane receptors have proteins (Letourneur and Klausner, 1992; Dietrich et al.,
been shown to associate via salt bridges formed by 1994, 1996, 1997) and in the binding of adaptor protein
acidic and basic amino acids in their transmembranes 1 (AP-1) and adaptor protein 2 (AP-2) (Dietrich et al.,
1997).(e.g., CD3/TcR [Morley et al., 1988; Bonifacino et al.,
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Figure 4. Expression of Transmembrane Mu-
tants of DAP12 and NKG2C
Ba/F3 cells stably expressing CD94/NKG2A,
CD94/NKG2A/Flag-DAP12, the D-A trans-
membrane NKG2C mutant, CD94/NKG2C/D-A
transmembrane Flag-DAP12 mutant, CD94/
K-L transmembrane NKG2C mutant, or CD94/
K-L transmembrane NKG2C mutant/Flag-
DAP12 receptors were stained with cIg, anti-
CD94 mAb, anti-Flag mAb, rabbit anti-CD94/
NKG2 antiserum, or the prebleed rabbit se-
rum (pre), as indicated. Data are presented
as in Figure 1.
Signal Transduction via CD94/NKG2C/DAP12 Flag-DAP12 mutant receptor with anti-Flag mAb did in-
duce tyrosine phosphorylation of cellular proteins (Fig-and KIR2DS2/DAP12 Complexes
Ligation of KIR2DS2 in transfectants expressing KIR2DS2/ ure 6B). Like NKG2A and NKG2C, the KIR2DS2 protein
has a counterpart, KIR2DL2, that lacks a charged aminoDAP12 complexes results in the tyrosine phosphoryla-
tion of DAP12 and other cellular substrates and the asso- acid in the transmembrane (Figure 3) and contains an
ITIM in its cytoplasmic domain. We previously reportedciation of phosphorylated DAP12 with Syk (Lanier et al.,
1998). Ligation of either CD94 or Flag-DAP12 on Ba/F3 that KIR2DL2 is unable to associate with DAP12 (Lanier
et al., 1998). Collectively, these findings indicate thattransfectants expressing CD94/NKG2C/DAP12 com-
plexes caused tyrosine phosphorylation of numerous the association of DAP12 with either KIR2DS2 or CD94/
NKG2C complexes likely results from interactions in-cellular proteins (Figure 5A), including DAP12 (Figure 5B)
and Syk (Figure 5C). These results indicate that cross- volving the transmembrane domains of these proteins.
The stoichiometry of DAP12 and KIR2DS2 or CD94/linking CD94/NKG2C induces cellular activation, pre-
sumably via DAP12. We were unable to address whether NKG2C in these complexes has not been determined.
A DAP12 disulfide-linked homodimer possesses two Dligation of CD94/NKG2C in the absence of DAP12 or in
transfectants expressing the D-A transmembrane Flag- residues (i.e., one in each DAP12 protein) that could
interact with the K residues present in the transmem-DAP12 mutant has functional consequences because
CD94/NKG2C was not efficiently expressed in the ab- branes of KIR2DS2 or NKG2C (Figure 3). Because CD94
lacks charged residues in the transmembrane (Figuresence of wild-type DAP12.
Unlike CD94/NKG2C, KIR2DS2 molecules are ex- 3), DAP12 may be able to function as an adaptor permit-
ting the association of two KIR2DS2 monomers or twopressed on the cell surface in the absence of DAP12,
although they are unable to induce cellular activation CD94/NKG2C heterodimers with a single DAP12 homo-
dimer. Further studiesare required toaddress this possi-(BleÂ ry et al., 1997; Lanier et al., 1998). KIR2DS21 Ba/F3
cells were infected with retroviruses encoding either bility. This model would be advantageous for more effi-
cient ligand binding and signal transduction.wild-type Flag-DAP12 or the D-A transmembrane Flag-
DAP12 mutant receptor. Both KIR2DS2 and the mutant
DAP12 protein were expressed on the cell surface.How- Association of DAP12 and CD94 in Human NK Cells
CD94/NKG2C receptors previously have been impli-ever, the D-A transmembrane Flag-DAP12 mutant pro-
tein was not coimmunoprecipitated with KIR2DS2 from cated in NKcell activation (Houchins et al., 1997; Cantoni
et al., 1998). An NK cell clone and a polyclonal NK cell125I-labeled transfectants (Figure 6A). Furthermore, liga-
tion with anti-KIR mAb failed to activate these cells, line were selected based on their ability to mediate redi-
rected cytotoxicity against the Fc receptor±bearingwhereas direct cross-linking of the D-A transmembrane
Activating NK Cell Receptors
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Figure 6. Coimmunoprecipitation of Wild-Type and Mutant KIR2DS2/
Flag-DAP12 Receptors and Cellular Activation
(A) Ba/F3 cells stably expressing KIR2DS2/Flag-DAP12 receptors
or KIR2DS2/D-A transmembrane Flag-DAP12 mutant receptors
Figure 5. Stimulation of CD94/NKG2C/Flag-DAP12 were 125I labeled and lysed in digitonin detergent, and antigens were
Ba/F3 cells stably expressing CD94 only or CD94/NKG2C/Flag- immunoprecipitated with cIg or anti-KIR2D mAb DX27. Samples
DAP12 receptors were stimulated with cross-linked cIg, anti-CD94 were analyzed by SDS±PAGE inreducing or nonreducing conditions.
mAb, or anti-Flag mAb, as indicated. 125I proteins with migration characteristics of monomeric Flag-
(A) Total cell lysates were resolved by SDS±PAGE (9% gels) and DAP12 ([R], reducing), dimeric Flag-DAP12 ([NR], nonreducing) and
analyzed by Western blot using an anti-phosphotyrosine mAb. KIR2DS2 are indicated. Anti-Flag mAb immunoprecipitated the 125I-
(B and C) Flag-DAP12 (B) and Syk (C) proteins were immunoprecipi- labeled D-A transmembrane Flag-DAP12 mutant protein, but did
tated and analyzed by Western blot using an anti-phosphotyrosine not coimmunoprecipitate KIR2DS2 from the transfectant expressing
mAb, as indicated. The multiple bands seen in (B) represent different both KIR2DS2 and the D-A transmembrane Flag-DAP12 mutant re-
phosphorylation species of DAP12. ceptor (not shown).
(B) Ba/F3 cells stably expressing KIR2DS2 only, KIR2DS2/Flag-
DAP12, or KIR2DS2/D-A transmembrane Flag-DAP12mutant recep-
P815 target cell in the presence of anti-CD94 mAb (not tors were stimulated with cross-linked cIg, anti-KIR2DS2 mAb DX27,
or anti-Flag mAb, as indicated. Total cell lysates were resolved byshown), suggesting the presence of an activating CD94-
SDS±PAGE (9% gels) and analyzed by Western blot using an anti-associated receptor complex, probably CD94/NKG2C
phosphotyrosine mAb.(Cantoni et al., 1998). The NK cell clone and the poly-
clonal NK cell line were 125I labeled and lysed in digitonin
detergent to preserve multisubunit receptor complexes, this. Nonetheless, these finding demonstrate the exis-
tence of a CD94/DAP12 receptor complex on the celland DAP12-associated proteins were coimmunoprecipi-
tated using an anti-DAP12 antiserum. DAP12-associ- surface of human NK cells.
ated proteins were eluted with a pH 11.5 buffer to disso-
ciate the complexes, and then the eluted proteins were Paired Activating and Inhibitory Receptors
The KIR gene family encodes receptors that have beenreimmunoprecipitated with a control mAb or anti-CD94
mAb. As shown in Figure 7 for the polyclonal NK cell implicated in either cellular activation or inhibition (Bias-
soni et al., 1996; Olcese et al., 1997). The inhibitoryline, anti-CD94 mAb specifically reacted with a 125I pro-
tein eluted from the initial anti-DAP12 immunoprecipi- receptors contain ITIM sequences in their cytoplasmic
domains and lack charged residues in the transmem-tate. On SDS±PAGE analysis, this molecule migrated at
z70 kDa in nonreducing conditions and z40 kDa in brane segments, whereas the activating receptors lack
ITIM, often have shorter cytoplasmic regions, and pos-reducing conditions. Equivalent results were obtained
using the NK cell clone (not shown). Because CD94 itself sess a charged amino acid in the transmembrane. This
general strategy is also evident in the NKG2 (Houchinsdoes not 125I label (Lazetic et al., 1996; Phillips et al.,
1996), it seems likely that the CD94-associated 125I- et al., 1991), Ly49 (Smith et al., 1994), PIR (Hayami et
al., 1997; Kubagawa et al., 1997), and ILT (LIR) (Borgeslabeled protein represents NKG2C, although NKG2C-
specific serological reagents are not available toconfirm et al., 1997; Samaridis and Colonna, 1997) gene families,
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expression of HLA-E. This model requires experimental
testing, but would provide defense against pathogens
that encode leader peptides competent to bind HLA-E,
but down-regulate expression of conventional MHC
class I molecules as a consequence of infection (Lanier,
1998a).
Experimental Procedures
Transfectants
cDNAs used were human CD94 (Chang et al., 1995), NKG2A (Hou-
chins et al., 1991), NKG2C (Houchins et al., 1991), KIR2DS2 (NKAT5
Figure 7. Association of CD94 and DAP12 in Human NK Cells [Colonna and Samaridis, 1995]), and Flag-DAP12 (Lanier etal., 1998).
A human polyclonal NK cell line was 125I labeled and lysed in digitonin The D-A transmembrane Flag-DAP12 mutant cDNA with an A resi-
detergent, and DAP12-associated antigens were immunoprecipi- due (codon GCC) substituted for the D residue (codon GAC) and
tated with affinity-purified rabbit anti-human DAP12 antiserum. the K-L transmembrane NKG2C mutant cDNA with an L residue
DAP12-associated proteins were eluted in 50 mM diethylamine (pH (TTA) substituted for K (codon AAA) were generated by PCR muta-
11.5), the eluates were neutralized in 1% NP-40 lysis buffer, and genesis using conventional techniques. An NKG2C cDNA containing
DAP12-eluted proteins were reimmunoprecipitated with anti-CD94 a Flag epitope on the COOH terminus immediately prior to the
mAb±coupled Sepharose beads or anti-NKR-P1A mAb±coupled NKG2C stop codon was generated by PCR. cDNAs were sequenced
Sepharose beads (used as a negative control (cIg) to demonstrate and subcloned into the pMX-neo or pMX-puro retroviral vectors
the specific interaction between DAP12and the CD94 receptor com- (Onihsi et al., 1996). Plasmid DNA was transfected into F-NX-E eco-
plex). NKR-P1A was used as a specificity control because prior tropic retrovirus packaging cells (a generous gift from G. Nolan,
studies demonstrated that while these NK cells express NKR-P1A Stanford University) using lipofectamine (GIBCO-BRL) (Onihsi et al.,
this molecule is not associated with DAP12 as determined by 1996). Viral supernatants were collected two days later and used to
cotransfection experiments (our unpublished data). Samples were infect mouse Ba/F3 pre-B cells (Onihsi et al., 1996). Two days post-
analyzed by SDS±PAGE in reducing and nonreducing conditions. infection, cells were switched to selection medium and Ba/F3 cells
The DAP12-associated protein reimmunoprecipitated with anti- stably expressing human NK cell receptors were sorted by flow
CD94 mAb migrated at z70 kDa under nonreducing conditions and cytometry for homogeneous high level expression.
z40 kDa in reducing conditions. As previously reported (Lazetic et
al., 1996; Phillips et al., 1996), CD94 does not 125I-label.
Antibodies and Flow Cytometry
mAbs used were anti-CD94 (DX22 [Phillips et al., 1996] or HP-3D9
mAb [Lopez-Botet, 1995]), anti-KIR2D mAb (DX27 [Phillips et al.,which all include potentially inhibitory and activating
1996]), anti-NKR-P1A (DX1 [Lanier et al., 1994]), anti-Flag (M2 mAb,receptors.
Kodak), anti-NKG2A/C (8E4mAb [Houchins et al., 1997]), andcontrol
We have shown that DAP12 associates with the acti- mouse IgG1 mAb (Becton Dickinson, San Jose, CA). Rabbit antise-
vating isoforms of both the KIR and CD94/NKG2 recep- rum specific for the CD94/NKG2A and CD94/NKG2C heterodimers
was prepared as described (Lazetic et al., 1996). FITC-conjugatedtors. The inhibitory CD94/NKG2A and activating CD94/
goat anti-rabbit Ig and FITC-conjugated anti-mouse Ig second anti-NKG2C receptors both bind the same ligand, HLA-E
bodies were purchased from CalTag (So. San Francisco, CA). Immu-(Braud et al., 1998). What is the biological rationale for
nofluorescence and flow cytometry were performed as describedpaired inhibitory and activating receptors recognizing (Lanier and Recktenwald, 1991).
MHC class I? The activating CD94/NKG2C/DAP12 re-
ceptor complex may function to stimulate tyrosine ki-
Biochemistrynases that phosphorylate the ITIM sequences in the
Transfected Ba/F3 cells were labeled with 125I and solubilized ininhibitory NKG2A receptor, resulting in the recruitment
digitonin lysis buffer (pH 7.8, 1% digitonin, 0.12% Triton X-100,
of SHP-1 or SHP-2 (Le Drean et al., 1998). However, this 150 mM NaCl, 20 mM triethanolamine, 0.01% NaN3, and protease
seems unlike since NKG2A and NKG2C are differentially inhibitors) (Lanier et al., 1989). Cell lysates were incubated on ice
for 2 hr with Pansorbin (Calbiochem) coated with rabbit anti-mouse/expressed within the total NK cell population and only
rat Ig (Sigma) and anti-CD94 (DX22 mAb), anti-Flag (M2 mAb) ora subset of NKcells expresses both receptors (Houchins
control IgG and then washed. Immunoprecipitates were resus-et al., 1997; Cantoni et al., 1998). The existence of NK
pended in SDS±PAGE sample buffer in the presence or absence ofcells expressing CD94/NKG2C, in the absence of the
10% 2-mercaptoethanol, run on 18% Tris/glycine gels (Novex), and
inhibitory CD94/NKG2A receptor, provides the potential visualized by using a PhosphorImager (Molecular Dynamics).
for activation of these cells upon encountering HLA-E. A human NK cell clone and a polyclonal human NK cell line
(CD32,CD561 peripheral blood NK cells cultured as described [YsselHLA-E is broadly expressed in normal tissues (Geraghty
et al., 1984]) were labeled with 125I and solubilized in digitonin lysiset al., 1992; Ulbrecht et al., 1992; Lee et al., 1998a);
buffer. 125I cell lysates were precleared overnight with Pansorbintherefore, activation of NK cells via CD94/NKG2C/
coated with rabbit Ig and then incubated on ice for 2 hr with Pansor-DAP12 might result in autoimmunity. However, recent
bin coated with an affinity-purified rabbit anti-DAP12 antiserum
studies suggest that all NK cell clones appear toexpress (generated by standard methods against a GST fusion protein con-
at least one inhibitory receptor (either a KIR or CD94/ taining the entire cytoplasmic domain of human DAP12). DAP12-
associated proteins were eluted in 25 ml of 50 mM diethylamine (pHNKG2A) against a self MHC class I ligand, thus pre-
11.5) and transferred to 0.5 ml 1% NP-40 lysis buffer (50 mM Tris,venting destruction of normal autologous tissues (Uhr-
150 mM NaCl [pH 8.0] containing protease inhibitors) with 10 mg/berg et al., 1997; Valiante et al., 1997). NK cell clones
ml BSA carrier protein. The DAP12-associated eluted proteins wereexpressing activating CD94/NKG2C/DAP12 receptors
reimmunoprecipitated with anti-CD94 mAb (HP-3D9 and DX22)±
and an inhibitory KIR against a self class I ligand could coupled Sepharose beads or anti-NKR-P1A mAb (DX1)±coupled
potentially recognize and eliminate host cells that have Sepharose beads (used as a negative control). Immunoprecipitates
were washed in 1% NP-40 lysis buffer, resuspended in SDS±PAGElost expression of the KIR class I ligand, but retained
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sample buffer in the presence or absence of 10% 2-mercaptoetha- Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E., and Brooks,
A.G. (1998). Recognition of human histocompatibility leukocyte anti-nol, run on 18% Tris/glycine gels, and visualized by using a Phos-
gen (HLA)-E complexed with HLA class I signal sequence-derivedphorImager.
peptides by CD94/NKG2 confers protection from natural killer cell-Western blot analysis using anti-Flag (M2 mAb) or anti-NKG2A/C
mediated lysis. J. Exp. Med. 187, 813±818.(8E4 mAb [Houchins et al., 1997]) was performed as described (Phil-
lips et al., 1996). 8E4 mAb detects both NKG2A and NKG2C by Braud, V., Jones, E.Y., and McMichael, A. (1997). The human major
Western blot analysis (Houchins et al., 1997), but does not immuno- histocompatibility complex class Ib molecule HLA-E binds signal
precipitate or bind to these antigens in immunofluorescence assays. sequence-derived peptides with primary anchor residues at posi-
tions 2 and 9. Eur. J. Immunol. 27, 1164±1169.
Braud, V.M., Allan, D.S.J., O'Callaghan, C.A., Soderstrom, K., D'An-Cellular Stimulation
drea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H.,Transfected Ba/F3 cells were suspended in cold PBS with 0.5%
Lanier, L.L., and McMichael, A.J. (1998). HLA-E binds to natural killerBSA at 5 3 107 cells/ml containing 20 mg/ml mAb recognizing CD94,
cell receptors CD94/NKG2A, B, and C. Nature 391, 795±798.Flag-DAP12, or KIR2DS2. Cells were incubated on ice for 30 min,
washed, resuspended in 10 mg/ml goat anti-mouse IgG F(ab9)2 (Jack- Brooks, A.G., Posch, P.E., Scorzelli, C.J., Borrego, F., and Coligan,
son Immunoresearch), and incubated for 3 min at 378C. Cells were J.E. (1997). NKG2A complexed with CD94 defines a novel inhibitory
pelleted, resuspended at 108/ml in ice-cold lysis buffer (1% NP-40, NK cell receptor. J. Exp. Med. 185, 795±800.
10 mM Tris [pH 7.4], 150 mM NaCl containing the protease and Brumbaugh, K.M., Perez-Villar, J.J., Dick, C.J., Schoon, R.A., Lopez-
phosphate inhibitors aprotinin, leupeptin, PMSF, EDTA, NaVO4, and Botet, M., and Leibson, P.J. (1996). Clonotypic differences in signal-
NaF) as described (Lanier et al., 1998). Syk and Flag-DAP12 were ing from CD94 (kp43) on NK cells lead to divergent cellular re-
immunoprecipitated with rabbit anti-Syk antiserum (generously pro- sponses. J. Immunol. 157, 2804±2812.
vided by Joe Bolen, DNAX) oranti-Flag (M2 mAb). Cell lysates (2±3 3 Burshtyn, D.N., Scharenberg, A.M., Wagtmann, N., Rajagopalan, S.,
106 cell equivalents) and immunoprecipitates were run on Tris/gly- Berrada, K., Yi, T., Kinet, J.-P., and Long, E.O. (1996). Recruitment
cine gels, blotted onto Immobilon membranes (Millipore), blocked, of tyrosine phosphatase HCP by the killer cell inhibitory receptor.
probed with horseradish peroxidase±conjugated anti-phosphotyro- Immunity 4, 77±85.
sine mAb 4G10 (Upstate Biotechnology), washed, and developed
Campbell, K.S., Dessing, M., Lopez-Botet, M., Cella, M., and Co-with a chemiluminescent substrate (Pierce).
lonna, M. (1996). Tyrosine phosphorylation of a human killer inhibi-
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